Keywords: net, income, leaps, pfizer, lipitor, becomes, world
Net income leaps 28% at Pfizer as Lipitor becomes world's best-selling drug
Article | 18 October 2001
Pfizer says that third-quarter 2001 net income increased 28% to $2.19billion, with diluted earnings per share rising 26% to $0.34, excluding the impact of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
